Volume 272, Number 5,
Issue of January 31, 1997
pp. 2821-2827
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Binding of the Brucella abortus Lipopolysaccharide
O-chain Fragment to a Monoclonal Antibody
QUANTITATIVE ANALYSIS BY FLUORESCENCE QUENCHING AND
POLARIZATION
(Received for publication, June 24, 1996, and in revised form, October 14, 1996)
Min
Lin
and
Klaus
Nielsen
From the Animal Diseases Research Institute, Nepean,
Ontario, Canada K2H 8P9
An antigenic O-chain polysaccharide fragment
derived from Brucella abortus lipopolysaccharide was
labeled with 14.8 ± 1.8 (n = 5) and 52.3 ± 2.4 (n = 3) µmol of fluorescein/g of polysaccharide (designated FL1 and FL2, respectively) for use
in investigating the binding of O-chain to a specific murine antibody
YsT9 under equilibrium conditions. Upon binding to YsT9, the
fluorescence of FL1 and FL2 was quenched
45-57% with no shift in the excitation and emission spectra, and
polarization of fluorescence increased by 300-335%. With fluorescence
quenching and polarization as sensitive signals for antibody-bound
labeled O-chains, the equilibrium constants for binding of
FL1, FL2, and unlabeled O-chain to YsT9 were
determined to be within a similar order (1.5 × 107 to
2.0 × 107 M
1) using a
nonlinear curve fitting approach rather than Scatchard analysis. These
results indicated that covalent attachment of fluorescein groups to the
O-chain did not influence the recognition of the YsT9-defined epitope
by the antibody. The reversibility of the O-chain-antibody reaction was
also demonstrated by showing a rapid depolarization of the labeled
O-chain-antibody complex in the presence of unlabeled O-chain,
suggesting that this displacement experiment could be exploited to
quantify the Brucella polysaccharide antigen. The study
described here provides a useful model for characterization of the
complex formation between a carbohydrate-binding protein and a
carbohydrate ligand and also for the design of a homogeneous assay
system to quantitate antigens or antibodies of clinical interest.